Ignite Creation Date:
2025-12-26 @ 11:46 AM
Ignite Modification Date:
2026-02-24 @ 5:51 AM
Study NCT ID:
NCT02900716
Status:
COMPLETED
Last Update Posted:
2020-11-27
First Post:
2016-08-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas
Sponsor:
Zhejiang DTRM Biopharma
Organization: